期刊文献+

Ⅱ型糖尿病肾病患者血清唾液酸水平及临床意义

下载PDF
导出
摘要 目的探讨血清唾液酸(SA)水平检测在Ⅱ型糖尿病肾病患者中的临床意义。方法选择2014年1月至2016年2月在该院住院的Ⅱ型糖尿病患者255例,根据尿微量清蛋白/肌酐比值(UACR)分为正常清蛋白尿组143例、微量清蛋白尿组56例、大量清蛋白尿组56例;另选择健康体检者38例为健康对照组。检测患者和健康对照组血清指标及SA,并进行统计学分析。结果Ⅱ型糖尿病患者血清SA水平(59.98±10.05)mg/dL显著高于健康对照组(55.06±5.97)mg/dL,差异有统计学意义(t=-3.29,P=0.001),随着疾病进展血清SA水平逐渐升高,差异有统计学意义(P<0.05)。血清SA诊断微量和大量清蛋白尿的ROC曲线下面积(AUC)分别为0.72(95%CI:0.66~0.79)和0.76(95%CI:0.69~0.750),后者优于前者,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示血清SA为糖尿病患者发生大量清蛋白尿的独立危险因素。结论血清SA与Ⅱ型糖尿病肾病密切相关,通过动态观察血清SA的变化有利于监测Ⅱ型糖尿病患者的病情进展情况。
作者 吕珏
出处 《国际检验医学杂志》 CAS 2017年第4期533-535,共3页 International Journal of Laboratory Medicine
  • 相关文献

参考文献5

二级参考文献71

  • 1李辉,李俭春,江时森,陈锐华.卡托普利对糖尿病大鼠血浆内皮素、唾液酸和脂质过氧化物的影响[J].中国糖尿病杂志,1997,5(2):119-120. 被引量:5
  • 2Johansson C, Nisson O, Baeckstrom D, et al. Novel epitopes on the CA50 carrying antigen: chemical and immunochemical studies. Tumour Biol, 1991, 12: 159-170.
  • 3Nisson O, Johansson C, Glimelius B, et al. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA19-9. Br J Cancer, 1992, 65:215-221.
  • 4Shukla VK, Gurubaehan, Sharma D, et al. Diagnostic value of serum CA242, CA19-9, CA15-3 and CA125 in patients with carcinoma of the gallbladder. Trop Gastroenterol, 2006, 27 : 160- 165.
  • 5Wu X, Lu XH, Qian JM, et al. Evaluation of the diagnostic value of serum tumor markers, and fecal K-ras and p53 gene mutations for pancreatic cancer. Chin J Dig Dis, 2006, 7 : 170-174.
  • 6Engaras B, Hafstrom L, Kewenter J, et al. Standard serum concentrations and normal fluctuations of CEA, CA50 and CA242 during twelve months in men and women aged 60-64 years without malignant disease. Eur J Surg, 1999,165:110-116.
  • 7Engaras B. Individual cutoff levels of carcinoembryonic antigen and CA242 indicate recurrence of colorectal cance with high sensitivity. Dis Colon Rectum, 2003,46:313-321.
  • 8Magnani JL, Nilsson B, Brockhaus M, et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated Lacto-N-fucopentaose Ⅱ. J Biol Chem, 1982, 257:14365-14369.
  • 9Petit JM, Vaillant G, Olsson NO, et al. Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group. Gastroenterol Clin Biol. 1994. 18: 17-20.
  • 10Szwergold BS. Intrinsic toxicity of glucose, duo to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines. Med Hypotheses, 2005, 65:337-348.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部